| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 07/14/2004 | EP1435925A2 Gap junctions and edhf |
| 07/14/2004 | EP1435918A1 Highly compressible ethylcellulose for tableting |
| 07/14/2004 | EP1435908A1 Oily paclitaxel composition and formulation for chemoembolization and preparation method thereof |
| 07/14/2004 | EP1435826A2 Diagnostic or therapeutic somatostatin or bombesin analog conjugates and uses thereof |
| 07/14/2004 | EP1365760A4 Preparations and use of an ah receptor ligand, 2-(1'h-indole-3'-carbonyl)-thiazole-4-carboxylic acid methyl ester |
| 07/14/2004 | EP1248776B1 Semi-synthetic taxanes with antitumor and antiangiogenetic activities |
| 07/14/2004 | EP1228067B1 5-membered n-heterocyclic compounds with hypoglycemic and hypolipidemic activity |
| 07/14/2004 | EP1224179B1 Sodium-hydrogen exchanger type 1 inhibitor crystals |
| 07/14/2004 | EP1210350B1 Water soluble sdz-rad esters |
| 07/14/2004 | EP1017823B1 Engineered protein kinases which can utilize modified nucleotide triphosphate substrates |
| 07/14/2004 | EP0983248B1 Analogs of duocarmycin and cc-1065 |
| 07/14/2004 | EP0961775B1 Purine l-nucleosides, analogs and uses thereof |
| 07/14/2004 | EP0934325B1 Mycophenolic bisphosphonate compounds |
| 07/14/2004 | EP0749442B1 ISOLATED p27 PROTEIN AND ITS ENCODING NUCLEIC ACID MOLECULES |
| 07/14/2004 | CN1512999A 2-{[N-(2-amino-3-(heteroaryl or aryl) propionyl)-aminoacyl]-amino}- alkylboronic acid derivatives |
| 07/14/2004 | CN1512994A Water soluble porphyri nderivatives for photodynamic therapy, their use and manufacture |
| 07/14/2004 | CN1512992A Novel adenine derivatives |
| 07/14/2004 | CN1512985A Aimoquinoline and aminopyridine derivatives and their use as adenosine A3 ligands |
| 07/14/2004 | CN1512983A Compounds and compositions as cathepsins inhibitors |
| 07/14/2004 | CN1512982A Novel polyamine analogues as therapeutic and diagnostic agents |
| 07/14/2004 | CN1512895A Use of polyclonal immunoglobulins |
| 07/14/2004 | CN1512894A Monocyte specific particulate delivery vehicle |
| 07/14/2004 | CN1512891A Epitope sequences |
| 07/14/2004 | CN1512890A HCG formulation |
| 07/14/2004 | CN1512888A Modified proteins, designer toxins and methosd of making thereof |
| 07/14/2004 | CN1512886A Use of antiprogestins for prophylaxis and treatment or hormone-dependent diseases |
| 07/14/2004 | CN1512881A Photosensitive and method for production thereof |
| 07/14/2004 | CN1512880A Novel compounds and compositions as cathepsin inhibitors |
| 07/14/2004 | CN1512876A Biofunctional hydroxyapatite coatings and microspheres for in-situ drug encapsulation |
| 07/14/2004 | CN1511861A Polyglycol fatty acid derivative and its medicinal combination |
| 07/14/2004 | CN1511848A Branched chain polyethylene glycol-integrated int3erferon composition and preparation |
| 07/14/2004 | CN1511847A Ubiquitin-like molecule coming from human dendritic cell and its codnig sequence and use |
| 07/14/2004 | CN1511835A Benzo-isoselenazole derivatives having anti inflammation, anti-tumor and anti-thrumbosis function and its use |
| 07/14/2004 | CN1511549A Composition containing scutellaria root for anti-tumor, anti-inflammation and tumor preventing medicine |
| 07/14/2004 | CN1511538A Use of scutellarin in inhibiting vascularization |
| 07/14/2004 | CN1511533A Use of bufadienolide in inhibiting vascularization |
| 07/14/2004 | CN1511531A Use of homoharringtonine and harringtonine in inhibiting vascularization |
| 07/14/2004 | CN1511528A Use of fangchinoline in vascularization inhibiting medicine |
| 07/14/2004 | CN1511527A Use of tetrandrine in inhibiting vascularization medicine |
| 07/14/2004 | CN1511522A Use of green chiretta diterpene lactone in inhibiting vascularization |
| 07/14/2004 | CN1511518A Use of chrysophanic acid in inhibiting vascularization |
| 07/14/2004 | CN1511517A Magnolol and/or use of magnolol and its derivative in inhibiting vascularization |
| 07/14/2004 | CN1157394C Dihydrofuro [3,4-b] quinoline-1-ketone type compound, its preparation method and medicinal composition containing these compounds |
| 07/14/2004 | CN1157382C New pyrimidine-2,4,6-trione derivatives, processes for their production and pharmaceutical agents cnotaining these compounds |
| 07/14/2004 | CN1157379C Tetrahydroquinoline derivatives |
| 07/14/2004 | CN1157226C Stable alpha-interferon preparation |
| 07/14/2004 | CN1157224C Novel amide derives. as growth hormone secretagogues |
| 07/14/2004 | CN1157223C Dolastatin-15 derivatives in combination with taxanes |
| 07/14/2004 | CN1157219C 治疗癌症的药物 Cancer drugs |
| 07/14/2004 | CN1157216C Toxic substance removing ointment and its preparing method |
| 07/14/2004 | CN1157215C Chinese medicine composition for curing cancers |
| 07/14/2004 | CN1157213C Chinese medicine composition for treating acute mastitis, mastroplasia and hysteromyoma |
| 07/14/2004 | CN1157204C Mother liquid medicine for treating liver cancer and its preparing process |
| 07/14/2004 | CN1157196C Galenic preparation for prevetion and treatment of hepatocarcinoma |
| 07/14/2004 | CN1157189C Semi-synthetic ecteinascidins |
| 07/14/2004 | CN1157185C Protein stabilized pharmacologically active agents, methods for preparation thereof and methods for use thereof |
| 07/13/2004 | US6762309 Antileukemia and antitumor agents |
| 07/13/2004 | US6762284 Used for medical applications, including diagnosis and treatment cell growth disorders like restenosis and cancer |
| 07/13/2004 | US6762205 Phenyl sulfamate derivatives |
| 07/13/2004 | US6762204 Taxol enhancer compounds |
| 07/13/2004 | US6762196 Use of 2-amino-4-pyridylmethyl-thiazoline derivatives as inhibitors of inducible no-synthase |
| 07/13/2004 | US6762195 Treating diseases mediated by tumor necrosis factor; inhibit angiogenesis and treatment of cancer, inflammatory, and autoimmune diseases |
| 07/13/2004 | US6762194 Quinolinone derivatives |
| 07/13/2004 | US6762179 (2-arylamino-4-thiazole)pyrimidine compounds; useful for treating diabetes, alzheimer's disease, stroke, proliferative disorders, and asthma |
| 07/13/2004 | US6762176 Inhibiting no-synthase enzymes producing nitrogen monoxide and/or trapping reactive forms of oxygen; inhibit lipidic peroxidation |
| 07/13/2004 | US6762175 Fatty acid derivatives |
| 07/13/2004 | US6762165 Snail venom; muscular disorders, central nervous system disorders, cardiovascular disorders |
| 07/13/2004 | US6761901 Proliposomal compositions that are advantageously used to deliver biologically active compounds to the gastrointestinal tract after oral administration. |
| 07/13/2004 | US6761878 Pathological tissue detection and treatment employing targeted benzoindole optical agents |
| 07/13/2004 | CA2386775C Drugs for the treatment of malignant tumours |
| 07/13/2004 | CA2268684C Process for alkylating hindered sulfonamides |
| 07/13/2004 | CA2238040C Sulfate conjugates of ursodeoxycholic acid, and their beneficial use in inflammatory disorders and other applications |
| 07/13/2004 | CA2131528C Methods and compositions for targeting the vasculature of solid tumors |
| 07/13/2004 | CA2047699C Expanded porphyrins: large prophyrin-like tripyrroledimethine-derived macrocycles |
| 07/08/2004 | WO2004057330A1 Method of screening cell growth inhibitor and cell growth inhibitor |
| 07/08/2004 | WO2004056998A1 The gene cluster involved in safracin biosynthesis and its uses for genetic engineering |
| 07/08/2004 | WO2004056991A2 Novel angiogenic molecular target and uses thereof |
| 07/08/2004 | WO2004056874A2 Neuropilin-1 inhibitors |
| 07/08/2004 | WO2004056832A2 Epothilone derivatives |
| 07/08/2004 | WO2004056830A1 Pyrrolopyrimidine derivatives |
| 07/08/2004 | WO2004056827A2 Substituted pyrrolo-pyrazole derivatives as kinase inhibitors |
| 07/08/2004 | WO2004056822A1 Pyridino `2, 3-d! pyrimidine derivatives as selective kdr and fgfr inhibitors |
| 07/08/2004 | WO2004056812A1 4- (pyridin-4-ylamino) -quinazoline derivatives as anti-tumor agents |
| 07/08/2004 | WO2004056806A1 2-(1h-indazol-6-ylamino)-benzamide compounds as protein kinases inhibitors useful for the treatment of ophtalmic diseases |
| 07/08/2004 | WO2004056801A1 Quinazoline derivatives |
| 07/08/2004 | WO2004056789A1 Mek inhibiting oxa- and thia-diazol-2-yl phenylamine derivates |
| 07/08/2004 | WO2004056766A1 Inhibitors of tace |
| 07/08/2004 | WO2004056747A1 Dhodh-inhibitors and method for their identification |
| 07/08/2004 | WO2004056746A1 Cycloalkene dicarboxylic acid compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents |
| 07/08/2004 | WO2004056738A1 Cyclopentenone derivatives for cancer therapy |
| 07/08/2004 | WO2004056387A1 Synthetic peptide analogs for the treatment of cancer |
| 07/08/2004 | WO2004056379A1 Saponins and sapogenins for use in combination therapy for cancer |
| 07/08/2004 | WO2004056376A1 Pharmaceutical formulations containing nitrate |
| 07/08/2004 | WO2004056372A1 Use of aglycon protopanaxadiol in cancer therapy |
| 07/08/2004 | WO2004056371A1 Use of aglycon protopanaxatriol in cancer therapy |
| 07/08/2004 | WO2004056367A1 Treatment of von hippel lindau disease |
| 07/08/2004 | WO2004056351A1 Pka activity regulator |
| 07/08/2004 | WO2004056350A1 Use of hypericin and/or the derivatives thereof for the prevention of primary tumours |
| 07/08/2004 | WO2004056307A2 Disease treatment via antimicrobial peptide inhibitors |
| 07/08/2004 | WO2004035611A8 Peptides binding the phosphatase 2a protein and polynucleotides encoding same |